Menu
  • Join
  • Login
  • Contact
 

Search abstracts


Development of a risk score for major bleeding associated with novel oral anticoagulants

  • At: 2016 FIP Congress in Buenos Aires (Argentina)
  • Type: Presentation
  • By: HERTIG, John (Purdue University College of Pharmacy, Center for Medication Safety Advancement, Indianapolis, United States)
  • Co-author(s): Janelle Lenz:Center for Medication Safety Advancement,Purdue University College of Pharmacy,Indianapolis,United States|John Hertig:|Dan Degnan:Center for Medication Safety Advancement,Purdue University College of Pharmacy,Indianapolis,United States|Heather Jaynes:|James Tisdale:Pharmacy Practice,Purdue University College of Pharmacy,Indianapolis,United States
  • Abstract:

    Use of novel oral anticoagulants (NOACs) is increasing. While risk scores exist for patients taking warfarin, a risk score for major bleeding associated in patients taking NOACs for a broad range of indications has not been developed. 

    In this retrospective study, Indiana University Health System medical records were used to identify patients that

    ..

  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 4 October 2019

FIP Congresses